Stay updated on M7824 With cCRT in Unresectable Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 With cCRT in Unresectable Stage III NSCLC Clinical Trial page.

Latest updates to the M7824 With cCRT in Unresectable Stage III NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page history adds a new version entry: Revision: v3.3.3. The deletions remove the HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer and history notes; there are no changes to trial data, status, or study details.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page footer revision banner updated from v3.3.1 to v3.3.2; no changes to study records or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page history shows a new revision entry v3.3.1 and removal of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoved the government funding operating-status banner from the page, and core trial data and record history remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedThe new screenshot shows a redesigned header and minor layout tweaks, while the underlying version history and study data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference10%

Stay in the know with updates to M7824 With cCRT in Unresectable Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 With cCRT in Unresectable Stage III NSCLC Clinical Trial page.